Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 206 Neoplasms 191 Carcinoma, Non-Small-Cell Lung 91 Colorectal Neoplasms 89 Prostatic Neoplasms 78 Lung Neoplasms 73 Multiple Myeloma 49 Head and Neck Neoplasms 47 Melanoma 46 Pancreatic Neoplasms 43 Neoplasm Metastasis 42 Leukemia, Myeloid, Acute 41 Carcinoma, Hepatocellular 40 Recurrence 34 Brain Neoplasms 34 Squamous Cell Carcinoma of Head and Neck 33 Ovarian Neoplasms 31 Glioblastoma 29 Precursor Cell Lymphoblastic Leukemia-Lymphoma 28 Glioma 27 Uterine Cervical Neoplasms 26 Sarcoma 26 Lymphoma, Non-Hodgkin 26 Lymphoma 26 Stomach Neoplasms 25 Lymphoma, Follicular 24 Carcinoma, Renal Cell 24 Esophageal Neoplasms 22 Colonic Neoplasms 22 Rectal Neoplasms 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Endometriosis × 90 days × Clear all

NCT04756037 2026-05-13

SERENE

Sumitomo Pharma Switzerland GmbH

Phase 3 Completed

1,164 enrolled 16 charts

Endometriosis, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡